CD5 Is A Potential Selecting Ligand for B-Cell Surface Immunoglobulin: A Possible Role in Maintenance and Selective Expansion of Normal and Malignant B Cells

References

• Foon K. A., Rai K. R., Gale R. P. Chronic lymphocytic leukemia: new insights into biology and therapy. Annals of Internal Medicine 1990; 113: 525–539
   PubMed Web of Science ®Google Scholar
• Herzenberg L. A., Cantor A. B., Herzenberg L. A. Layered evolution in the immune system. Annals of the New York Academy of Sciences 1992; 651: 1–9
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals tor the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. Journal of Clinical Pathology 1989; 42: 567–584
   PubMed Web of Science ®Google Scholar
• Jennings C. D., Foon K. A. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 1997; 90: 2863–2892
   PubMed Web of Science ®Google Scholar
• Pospisil R., Fitts M. G., Mage R. G. CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences. Journal of Experimental Medicine 1996; 184: 1279–1284
   PubMed Web of Science ®Google Scholar
• Pospisil R., Mage R. G. CD5 and other superantigens as ‘ticklers’ of the B cell receptor. Immunology Today 1998; 19: 106–108
   PubMedGoogle Scholar
• Starling S. G. C., Llewellyn M. B., Whitney G. S., Aruffo A. The Ly-1.1 and Ly-1.2 epitopes of murine CD5 map to the membrane distal scavenger receptor cys-teine-rich domain. Tissue Antigens 1997; 49: 1–6
   PubMed Web of Science ®Google Scholar
• Aruffo A., Bowen M. A., Patel D. D., Haynes B. F., Starling G. C., Gebe J. A., Bajorath J. CD6-ligand interactions: a paradigm for SRCR domain function?. Immunology Today 1997; 18: 498–504
   PubMedGoogle Scholar
• Matsuda F., Shin E. K., Nagaoka H., Matsumura R., Haino M., Fukita Y., Taka-Ishi S., Imai T., Riley J. H., Anand R., Soeda E., Honjo T. Structure and physical map of 64 variable segments in the 3′0.8-megabase region of the human immunoglobulin heavy-chain locus. Nature Genetics 1993; 3: 88–94
   PubMed Web of Science ®Google Scholar
• Tomlinson I. M., Walter G., Marks J. D., Llewelyn M. B., Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. Journal of Molecular Biology 1992; 227: 776–798
   PubMed Web of Science ®Google Scholar
• Cook G. P., Tomlinson I. M., Walter G., Riethman H., Carter N. P., Buluwela L., Winter G., Rabbitts T. H. A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nature Genetics 1994; 7: 162–242
   PubMed Web of Science ®Google Scholar
• Pascual V., Capra J. D. Human immunoglobulin heavy-chain variable region genes: organization, polymorphism, and expression. Advances in Immunology 1991; 49: 1–74
   PubMed Web of Science ®Google Scholar
• Cook G. P., Tomlinson I. M. The human immunoglobulin VH repertoire. Immunology Today 1995; 16: 237–242
   PubMedGoogle Scholar
• Maloum K., Pritsch O., Magnac C., Davi F., Binet J. L., Merle-Beral H., Dighiero G. VH gene expression in CD5 positive and CD5 negative B cell chronic lymphoid malignancies. Leukemia and Lymphoma 1997; 24: 437–448
   PubMed Web of Science ®Google Scholar
• Kipps T. J. Immunoglobulin genes in chronic lymphocytic leukaemia. Blood Cells 1993; 19: 615–625
   PubMedGoogle Scholar
• Dighiero G., Kipps T., Schroeder H. W., Chiorazzi N., Stevenson F., Silberstein L. E., Caligaris-Cappio E., Ferrarini M. What is the CLL B-lymphocyte?. Leukemia and Lymphoma (Suppl 2) 1996; 22: 13–39
   PubMed Web of Science ®Google Scholar
• Sasso E. H., Johnson T., Kipps T. J. Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number. Journal of Clinical Investigation 1996; 97: 2074–2080
   PubMed Web of Science ®Google Scholar
• Kraj P., Friedman D. F., Stevenson E., Silberstein L. E. Evidence for the overexpression of the VH4–34 (VH4.21) Ig gene segment in the normal adult human peripheral blood B cell repertoire. Journal of Immunology 1995; 154: 6406–6420
   PubMed Web of Science ®Google Scholar
• Kraj P., Rao S. P., Glas A. M., Hardy R. R., Milner E. C. B., Silberstein L. E. The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells. Journal of Immunology 1997; 158: 5824–5832
   PubMed Web of Science ®Google Scholar
• Brezinschek H. P., Foster S. J., Brezinschek R. I., Dorner T., Domiati-Saad R., Lipsky P. E. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. Journal of Clinical Investigation 1997; 99: 2488–2501
   PubMed Web of Science ®Google Scholar
• Hashimoto S., Dono M., Wakai M., Allen S. L., Lichtman S. M., Schulman P., Vinciguerra V. P., Ferrarini M., Silver J., Chiorazzi N. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. Journal of Experimental Medicine 1995; 181: 1507–1517
   PubMed Web of Science ®Google Scholar
• Matolcsy A., Casali P., Nador R. G., Liu Y. F., Knowles D. M. Molecular characterization of IgA-and/or IgG-switched chronic lymphocytic leukemia B cells. Blood 1997; 89: 1732–1739
   PubMed Web of Science ®Google Scholar
• Cai J., Humphries C., Richardson A., Tucker P. W. Extensive and selective mutation of a rearranged VH5 gene in human chronic lymphocytic leukemia. Journal of Experimental Medicine 1992; 176: 1073–1081
   PubMed Web of Science ®Google Scholar
• Fais F., Ghiotto F., Hashimoto S., Sellers B., Valetto A., Allen S. L., Schulman P., Vinciguerra V. P., Rai K., Ras-Senti L. Z., et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. Journal of Clinical Investigation 1998; 102: 1515–1525
   PubMed Web of Science ®Google Scholar
• Liu Y. J., Arpin C. Germinal center development. Immunological Reviews 1997; 156: 111–126
   PubMed Web of Science ®Google Scholar
• Pascual V., Liu Y. J., Magalski A., de Bouteiller O., Banchereau J., Capra J. D. Analysis of somatic mutation in five B cell subsets of human tonsil. Journal of Experimental Medicine 1994; 180: 329–339
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Gobbi M., Bofill M., Janossy G. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. Journal of Experimental Medicine 1982; 155: 623–628
   PubMed Web of Science ®Google Scholar
• Schena M., Larsson L. G., Gottardi D., Gaidano G., Carlsson M., Nilsson K., Caligaris-Cappio E. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 1992; 79: 2981–2989
   PubMed Web of Science ®Google Scholar
• Hanada M., Delia D., Aiello A., Stadtmauer E., Reed J. C. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1820–1828
   PubMed Web of Science ®Google Scholar
• Gottardi D., Alfarano A., De Leo A. M., Stacchini A., Aragno M., Rigo A., Veneri D., Zanotti R., Pizzolo G., Caligaris-Cappio F. In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis. British Journal of Haematology 1996; 94: 612–618
   PubMed Web of Science ®Google Scholar
• Tangye S. G., Raison R. L. Leukaemic CD5+ B-cell apoptosis: coincidence of cell death and DNA fragmentation with reduced bcl-2 expression. British Journal of Haematology 1996; 92: 950–953
   PubMed Web of Science ®Google Scholar
• Kobayashi R., Rassenti L. Z., Meisenholder G., Carson D. A., Kipps T. J. Autoantigen inhibits apoptosis of a human B cell leukemia that produces pathogenic rheumatoid factor. Journal of Immunology 1993; 151: 7273–7283
   PubMed Web of Science ®Google Scholar
• Wendel-Hansen V., Sallstrom J., DeCampos-Lima P. O., Kjellstrom G., Sandlund A., Siegbahn A., Carlsson M., Nilsson K., Rosen A. Epstein-Barr virus (EBV) can immortalize B-cells activated by cytokines. Leukemia 1994; 8: 476–484
   PubMed Web of Science ®Google Scholar
• Melo J. V., Brito-Babapulle V., Foroni L., Robinson D. S., Luzzatto L., Catovsky D. Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. International Journal of Cancer 1986; 38: 531–538
   PubMed Web of Science ®Google Scholar
• Bowen M. A., Bajorath J., Siadak A. W., Modrell B., Mal-Acko A. R., Marquardt H., Nadler S. G., Aruffo A. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry. Journal of Biological Chemistry 1996; 271: 17390–17396
   PubMed Web of Science ®Google Scholar
• Aruffo A., Stamenkovic I., Melnick M., Underhill C. B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1995; 61: 1303–1313
   Web of Science ®Google Scholar
• Hollenbaugh D., Douthwright J., McDonald V., Aruffo A. Cleavable CD40Ig fusion proteins and the binding to sgp39. Journal of Immunological Methods 1995; 188: 1–7
   PubMed Web of Science ®Google Scholar
• Pospisil R., Mage R. G. Rabbit Appendix - A Site of Development and Selection of the B-Cell Repertoire. Current Topics in Microbiology and Immunology 1997; 229: 59–70
   Web of Science ®Google Scholar
• Marti G. E., Zenger V., Caporaso N. E., Brown M., Washington G. C., Carter P., Schechter G., Noguchi P. Antigenic expression of B-cell chronic lymphocytic leukemic lymphocytes. Analytical Quantitative Cytology and Histology 1989; 11: 315–323
   PubMed Web of Science ®Google Scholar
• Marti G. E., Zenger V., Brown M., Marti D. M., Melo J. V., Crescenzi M., Dadey B., Han T., Benin P., Caporaso N. E., Noguchi P. Antigenic expression of B-cell chronic lymphocytic leukemic cell lines. Leukemia and Lymphoma 1992; 7: 497–504
   PubMed Web of Science ®Google Scholar
• Martin P. J., Hansen J. A., Siadak A. W., Nowinski R. Monoclonal antibodies recognizing normal human T lymphocytes and malignant human B lymphocytes: a comparative study. Journal of Immunology 1981; 127: 1920–1923
   PubMed Web of Science ®Google Scholar
• Pratt L. E., Szubin R., Carson D. A., Kipps T. J. Molecular characterization of a supratypic cross-reactive idiotype associated with IgM autoantibodies. Journal of Immunology 1991; 147: 2041–2048
   PubMed Web of Science ®Google Scholar
• Kipps T. J., Duffy S. F. Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoanti-body-associated cross-reactive idiotypes. Journal of Clinical Investigation 1991; 87: 2087–2096
   PubMed Web of Science ®Google Scholar
• Schwartz R. S., Stollar B. D. Heavy-chain directed B-cell maturatiomcontinuous clonal selection beginning at the pre-B cell stage. Immunology Today 1994; 15: 27–32
   PubMedGoogle Scholar
• Zouali M. B-cell superantigens: implications for selection of the human antibody repertoire. Immunology Today 1995; 16: 399–405
   PubMedGoogle Scholar
• Silverman G. J. B-cell superantigens. Immunology Today 1997; 18: 379–386
   PubMedGoogle Scholar
• Silverman G. J., Nayak J. V., Warnatz K., Hajjar F. E., Cary S., Tighe H., Curtiss V. E. The dual phases of the response to neonatal exposure to a VH family-restricted staphylococcal B cell superantigen. Journal of Immunology 1998; 161: 5720–5732
   PubMed Web of Science ®Google Scholar
• Mongini P., Highet P., Inman J. Requirements for mIgM-triggered activation versus apoptosis in human B cells. Annals of the New York Academy of Sciences 1997; 815: 469–471
   PubMed Web of Science ®Google Scholar
• Lam K-P., Kuhn R., Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1996; 90: 1073–1083
   Web of Science ®Google Scholar
• Amariglio N., Rechavi G. Do superantigens play a role in lymphoproliferation?. Leukemia and Lymphoma 1996; 22: 237–243
   PubMed Web of Science ®Google Scholar
• Van de Velde H., von Hoegen I., Luo W., Parnes J. R., Thielemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 1991; 351: 662–665
   PubMed Web of Science ®Google Scholar
• Biancone L., Bowen M. A., Lim A., Aruffo A., Andres G., Stamenkovic I. Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. Journal of Experimental Medicine 1996; 184: 811–819
   PubMed Web of Science ®Google Scholar
• Bikah G., Carey J., Ciallella J. R., Tarakhovsky A., Bondada S. CDS-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 1996; 274: 1906–1909
   PubMed Web of Science ®Google Scholar
• Cerutti A., Trentin L., Zambello R., Sancetta R., Milani A., Tassinari C., Adami F., Agostini C., Semenzato G. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity. Journal of Immunology 1996; 157: 1854–1862
   PubMed Web of Science ®Google Scholar
• Raman C., Kuo A., Deshane J., Litchfield D. W., Kimberly R. P. Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5. Journal of Biological Chemistry 1998; 273: 19183–19189
   PubMed Web of Science ®Google Scholar
• Raman C., Kimberly R. P. Differential CD5-dependent regulation of CD5-associated CK2 activity in mature and immature T cells: implication on TCR/CD3-mediated activation. Journal of Immunology 1998; 161: 5817–5820
   PubMed Web of Science ®Google Scholar
• Lankester A. C., van Schijndel G. M., van der Schoot C. E., van Oers M. H., van Noesel C. J., van Lier R. A. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. Blood, 86: 1090–1097
   PubMed Web of Science ®Google Scholar
• Nieuwenhuis P., Ford W. L. Comparative migration of B- and T-Lymphocytes in the rat spleen and lymph nodes. Cellular Immunology 1976; 23: 254–267
   PubMed Web of Science ®Google Scholar
• Jacob J., Kassir R., Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophe-nyl)acetyl. I. The architecture and dynamics of responding cell populations. Journal of Experimental Medicine 1991; 173: 1165–1175
   PubMed Web of Science ®Google Scholar
• Liu Y. J., Zhang J., Lane P. J., Chan E. Y., MacLennan I. C. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. European Journal of Immunology 1991; 21: 2951–2962
   PubMed Web of Science ®Google Scholar
• Lortan J. E., Roobottom C. A., Oldfield S., MacLennan I. C. Newly produced virgin B cells migrate to secondary lymphoid organs but their capacity to enter follicles is restricted. European Journal of Immunology 1987; 17: 1311–1316
   PubMed Web of Science ®Google Scholar
• Forster R., Mattis A. E., Kremmer E., Wolf E., Brem G., Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996; 87: 1037–1047
   PubMed Web of Science ®Google Scholar
• Klinman N. R. The “clonal selection hypothesis” and current concepts of the B cell tolerance. Immunity 1996; 5: 189–195
   PubMed Web of Science ®Google Scholar
• Hayakawa K., Hardy R. R., Herzenberg L. A. Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. European Journal of Immunology 1986; 16: 450–456
   PubMed Web of Science ®Google Scholar
• Forster I., Rajewsky K. Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. European Journal of Immunology 1987; 17: 521–528
   PubMed Web of Science ®Google Scholar
• Kipps T. J., Tomhave E., Pratt L. R., Duffy S., Chen P. P., Carson D. A. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences USA 1989; 86: 5913–5917
   PubMed Web of Science ®Google Scholar
• Deane M., Norton J. D. Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B-lineage leukaemias. Leukemia 1991; 5: 646–650
   PubMed Web of Science ®Google Scholar
• Pascual V., Wilson P., Liu Y. J., Banchereau J., Capra J. D. Biased VH4 gene segment repertoire in the human tonsil. Chemical Immunology 1994; 67: 45–57
   Google Scholar
• Goodglick L., Braun J. Revenge of the microbes. Superantigens of the T and B cell lineage. American Journal of Pathology 1994; 144: 623–636
   PubMed Web of Science ®Google Scholar
• Domiati-Saad R., Attrep J. F., Brezinschek H. P., Cherrie A. H., Karp D. R., Lipsky P. E. Staphylococcal enterotoxin D functions as a human B cell superantigen by rescuing VH4-expressing B cells from apoptosis. Journal of Immunology 1996; 156: 3608–3620
   PubMed Web of Science ®Google Scholar
• McAlister M. S.B., Brown M. H., Willis A. C., Rudd P. M., Harvey D. J., Aplin R., Shotton D. M., Dwek R. A., Barclay A. N., Driscoll P. C. Structural analysis of the CD5 antigen expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1. European Journal of Biochemistry 1998; 257: 131–141
   PubMedGoogle Scholar
• Hohenester E., Sasaki T., Timpl R. Crystal structure of a scavenger receptor cysteine rich domain sheds light on an ancient superfamily. Nature Structural Biology 1999; 6: 228–232
   PubMedGoogle Scholar